argenx SE reported $48.77B in Market Capitalization this October of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AstraZeneca USD 215.06B 74.93B Oct/2026
Genmab DKK 17.1B 88.06B Jun/2026
GlaxoSmithKline GBP 74.9B 785.69M Oct/2026
GRIFOLS EUR 5.41B 181.49M Jun/2026
Hikma Pharmaceutical USD 4.63B 1.42B Dec/2025
Lakefront Biotherapeutics EUR 1.73B 2.64M Jun/2026
Qiagen NV USD 8.07B 197.36M Jun/2026
UCB EUR 46.41B 13.94B Dec/2025